Optimizing weight control in diabetes: antidiabetic drug selection

Código QR

Optimizing weight control in diabetes: antidiabetic drug selection

S Kalra1, B Kalra1, AG Unnikrishnan2, N Agrawal3, S Kumar41Bharti Hospital, Karnal; 2Amrita Institute of Medical Science, Kochi; 3Medical College, Gwalior; 4Excel Life Sciences, Noida, IndiaDate of preparation: 18th August 2010Conflict of interest: SK has received speaker fees from Novo Nordisk, san...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Kalra S
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2010
Materias:	weight control diabetes antidiabetic drugs Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/f156546818cd4b9fb6e2e02aca6296a7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Optimizing weight control in diabetes: antidiabetic drug selection
por: S Kalra, et al.
Publicado: (2010)

In vivo Antidiabetic Activity Evaluation of Aqueous and 80% Methanolic Extracts of Leaves of Thymus schimperi (Lamiaceae) in Alloxan-induced Diabetic Mice
por: Melesie Taye G, et al.
Publicado: (2020)

Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
por: Levin PA, et al.
Publicado: (2017)

SGLT2 Inhibitors as Add-On Therapy to Metformin for People with Type 2 Diabetes: A Review of Placebo-Controlled Trials in Asian versus Non-Asian Patients
por: Scheen AJ
Publicado: (2020)

Practical combination therapy based on pathophysiology of type 2 diabetes
por: Levin PA
Publicado: (2016)

Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
por: Pscherer S, et al.
Publicado: (2016)

Reasons for discontinuation of GLP1 receptor agonists: data from a real-world cross-sectional survey of physicians and their patients with type 2 diabetes
por: Sikirica MV, et al.
Publicado: (2017)

Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes
por: Wake AD
Publicado: (2020)

Antihyperglycemic Activity of TLC Isolates from the Leaves of Aloe megalacantha Baker in Streptozotocin-Induced Diabetic Mice
por: Araya TY, et al.
Publicado: (2021)

Efficacy and safety profile of once-weekly dulaglutide in type 2 diabetes: a report on the emerging new data
por: Kugler AJ, et al.
Publicado: (2018)

Glycemic control and diabetes complications among diabetes mellitus patients attending at University of Gondar Hospital, Northwest Ethiopia
por: Fasil A, et al.
Publicado: (2018)

Effect of Pleurotus fossulatus Aqueous Extract on Biochemical Properties of Liver and Kidney in Streptozotocin-Induced Diabetic Rat
por: Dubey S, et al.
Publicado: (2020)

Drug-Related Problems and Their Predictors Among Patients with Diabetes Attending the Ambulatory Clinic of Gebre Tsadik Shawo General Hospital, Southwest Ethiopia
por: Mechessa DF, et al.
Publicado: (2020)

Antidiabetic effect of glucosaminic acid-cobalt (II) chelate in streptozotocin-induced diabetes in mice
por: Talba T, et al.
Publicado: (2011)

Lifestyle Intervention for Weight Loss: a group-based program for Emiratis in Ajman, United Arab Emirates
por: Sadiya A, et al.
Publicado: (2016)

Antidiabetic and Anti-hyperlipidemic Effects of the Crude Hydromethanol Extract of Hagenia abyssinica (Rosaceae) Leaves in Streptozotocin-Induced Diabetic Mice
por: Kifle ZD, et al.
Publicado: (2020)

Association Between Severity of Diabetic Neuropathy and Success in Weight Loss During Hospitalization Among Japanese Patients with Type 2 Diabetes: A Retrospective Observational Study
por: Nakanishi S, et al.
Publicado: (2020)

Determinants of Diabetic Complication Among Adult Diabetic Patients in Debre Markos Referral Hospital, Northwest Ethiopia, 2018: Unmatched Case Control Study
por: Kidanie BB, et al.
Publicado: (2020)

Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice
por: Jarrar YB, et al.
Publicado: (2018)

Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
por: Wilke T, et al.
Publicado: (2019)

Evaluation of Antidiabetic Effect of Ethanolic Leaves Extract of Becium grandiflorum Lam. (Lamiaceae) in Streptozotocin-Induced Diabetic Mice
por: Gebremeskel L, et al.
Publicado: (2020)

Smartphone applications to aid weight loss and management: current perspectives
por: Sutton EF, et al.
Publicado: (2016)

Antidiabetic and Nephroprotective Effects of Polysaccharide Extract from the Seaweed Caulerpa racemosa in High Fructose-Streptozotocin Induced Diabetic Nephropathy
por: Cao M, et al.
Publicado: (2021)

Glycemic Control, Diabetes Complications and Their Determinants Among Ambulatory Diabetes Mellitus Patients in Southwest Ethiopia: A Prospective Cross-Sectional Study
por: YimamAhmed M, et al.
Publicado: (2020)

When Inappropriate Use of Insulin is Dangerous: The Utility of C-Peptide Assay in the Era of Cardioprotective Antidiabetic Drugs
por: Volpe S, et al.
Publicado: (2021)

Potent antiatherosclerotic effects of alogliptin in addition to its potent antidiabetic effects
por: Kapoor S
Publicado: (2012)

Risk of Thyroid Cancer Associated with Use of Liraglutide and Other Antidiabetic Drugs in a US Commercially Insured Population
por: Funch D, et al.
Publicado: (2021)

The Prevalence and Control of Type 2 Diabetes Mellitus in Residents of a Rural Town, Shandong Province, China
por: Wei M, et al.
Publicado: (2021)

Prevalence of diabetes and obesity in association with prematurity and growth restriction
por: Kopec G, et al.
Publicado: (2017)

Assessing the effect of weight and weight loss in obese persons with type 2 diabetes
por: Bradley Curtis, et al.
Publicado: (2008)

Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes
por: Via MA
Publicado: (2010)

Tackling obesity: new therapeutic agents for assisted weight loss
por: McFarlane S
Publicado: (2010)

Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds
por: Nie X, et al.
Publicado: (2020)

Critical appraisal of the safety and efficacy of insulin detemir in glycemic control and cardiovascular risk management in diabetics
por: Le Floch J
Publicado: (2010)

Predictors of weight loss and maintenance in patients treated with antiobesity drugs
por: Guaraldi F, et al.
Publicado: (2011)

Improvement in Cardiometabolic Risk Factors During Smoking Cessation Treatment in Patients with Type 2 Diabetes: A Retrospective Cohort Study
por: Chen HJ, et al.
Publicado: (2021)

Weight loss medications in Canada – a new frontier or a repeat of past mistakes?
por: Wharton S, et al.
Publicado: (2017)

The prevalence and determinants of poor glycemic control among adults with type 2 diabetes mellitus in Saudi Arabia
por: Alzaheb RA, et al.
Publicado: (2018)

Clinical effectiveness of quercetin supplementation in the management of weight loss: a pooled analysis of randomized controlled trials
por: Huang H, et al.
Publicado: (2019)

Cognitive impairment in patients with type 2 diabetes mellitus: prevalence, pathogenetic mechanisms, the effect of antidiabetic drugs
por: Olga D. Ostroumova, et al.
Publicado: (2018)